CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy · Terms of Service · Privacy FAQ

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Flywheel›
Products & Services›
Flywheel Platform›
News
Flywheel Platform

Flywheel Platform

ServiceOperating Status: Currently Offered

Flywheel manages imaging data across research, clinical trials, and AI workflows.

Loading
Overview
Analysis
News

Latest News About Flywheel Platform

Flywheel Announces Integration with AWS HealthImaging to Activate Imaging Data for Clinical Trials and AI Development

Flywheel

Flywheel Announces Integration with AWS HealthImaging to Activate Imaging Data for Clinical Trials and AI Development

Flywheel announced an integration with AWS HealthImaging to support governed imaging workflows for clinical development, research,...

May 19, 2026

Flywheel reports record growth and product launches for clinical trial and medical device markets

Flywheel

Flywheel reports record growth and product launches for clinical trial and medical device markets

Flywheel reported 2025 product launches for clinical trial and medical-device workflows, including video viewing and annotation...

Jan 8, 2026

Flywheel Launches Validated Imaging Solution to Accelerate Decision-Making Across the Clinical Trial Ecosystem

Flywheel

Flywheel Launches Validated Imaging Solution to Accelerate Decision-Making Across the Clinical Trial Ecosystem

Flywheel announced Flywheel Validated, a clinical-trial imaging solution with guided site uploads, validated reads, quality control, audit...

Dec 2, 2025

Flywheel and Mint Medical Announce Collaboration to Expedite Research and Clinical Trial Workflows with Enhanced Oncology Imaging Solution

Flywheel

Flywheel and Mint Medical Announce Collaboration to Expedite Research and Clinical Trial Workflows with Enhanced Oncology Imaging Solution

Flywheel and Mint Medical announced an integration connecting imaging data management with structured radiology analysis for oncology...

Jul 8, 2024

Voximetry Partners with Flywheel to Assure Confidence in Data Management, Security and Privacy for Clinical Dosimetry Services

Flywheel

Voximetry Partners with Flywheel to Assure Confidence in Data Management, Security and Privacy for Clinical Dosimetry Services

Voximetry and Flywheel announced a workflow for secure transfer and de-identification of clinical imaging data to support remote...

May 31, 2024

Revolutionizing Medical AI Development: Flywheel Announces $54 Million in Series D Funding led by Novalis LifeSciences and NVentures

Flywheel

Revolutionizing Medical AI Development: Flywheel Announces $54 Million in Series D Funding led by Novalis LifeSciences and NVentures

Flywheel announced a $54 million Series D financing co-led by Novalis LifeSciences and NVentures, with participation from Microsoft and...

Jun 27, 2023